Fast reading
- Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers.
- EOS has engaged it on this topic for the past 16 months to increase investor confidence in the company for the long term.
Takeda Pharmaceutical Case Study October 2020
Share:
Case studies are shown to demonstrate engagement, EOS does not make any investment recommendations and the information is not an offer to buy or sell securities.
